Herantis Pharma Oyj (HRTIS) - Total Liabilities

Latest as of June 2025: €3.36 Million EUR ≈ $3.93 Million USD

Based on the latest financial reports, Herantis Pharma Oyj (HRTIS) has total liabilities worth €3.36 Million EUR (≈ $3.93 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Herantis Pharma Oyj growing its equity to track the company's year-over-year net asset growth rate.

Herantis Pharma Oyj - Total Liabilities Trend (2011–2024)

This chart illustrates how Herantis Pharma Oyj's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Herantis Pharma Oyj to measure how efficiently the company converts operating cash flow to free cash.

Herantis Pharma Oyj Competitors by Total Liabilities

The table below lists competitors of Herantis Pharma Oyj ranked by their total liabilities.

Company	Country	Total Liabilities
Y/KNOT S.A. AT:YKNOT	Greece	€29.83 Million
Sonel S.A. WAR:SON	Poland	zł27.03 Million
Nam Kwang Cons KO:001260	Korea	₩276.26 Billion
EgnsINVEST Ejendomme Tyskland A/S CO:EGNETY	Denmark	Dkr846.76 Million
Evrofarma SA AT:EVROF	Greece	€34.79 Million
Experience Co Ltd AU:EXP	Australia	AU$62.72 Million
York Timber Holdings Ltd JSE:YRK	South Africa	ZAC1.86 Billion
Ozerden Plastik Sanayi IS:OZRDN	Turkey	TL52.79 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Herantis Pharma Oyj's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Herantis Pharma Oyj market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.10	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.71	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.92	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.66	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Herantis Pharma Oyj's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Herantis Pharma Oyj (2011–2024)

The table below shows the annual total liabilities of Herantis Pharma Oyj from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	€2.81 Million ≈ $3.29 Million	+39.36%
2023-12-31	€2.02 Million ≈ $2.36 Million	-67.91%
2022-12-31	€6.29 Million ≈ $7.36 Million	-1.12%
2021-12-31	€6.36 Million ≈ $7.44 Million	-27.95%
2020-12-31	€8.83 Million ≈ $10.33 Million	-4.19%
2019-12-31	€9.22 Million ≈ $10.78 Million	+27.40%
2018-12-31	€7.24 Million ≈ $8.46 Million	-3.28%
2017-12-31	€7.48 Million ≈ $8.75 Million	-13.31%
2016-12-31	€8.63 Million ≈ $10.09 Million	+6.69%
2015-12-31	€8.09 Million ≈ $9.46 Million	+4.05%
2014-12-31	€7.77 Million ≈ $9.09 Million	+208.39%
2013-12-31	€2.52 Million ≈ $2.95 Million	+13.82%
2012-12-31	€2.21 Million ≈ $2.59 Million	+15.35%
2011-12-31	€1.92 Million ≈ $2.24 Million	--

About Herantis Pharma Oyj

HE:HRTIS Finland Biotechnology

Market Cap

$52.37 Million

€44.79 Million EUR

Market Cap Rank

#21697 Global

#108 in Finland

Share Price

€1.69

Change (1 day)

-1.05%

52-Week Range

€1.58 - €2.78

All Time High

€10.10